Germany
Japan
United Kingdom
China
Lenti ORF particles, PLA2G3 (Myc-DDK tagged) - Human phospholipase A2, group III (PLA2G3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
- LentiORF®
-
Products
Lenti ORF particles, PLA2G3 (mGFP-tagged) - Human phospholipase A2, group III (PLA2G3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
- LentiORF®
-
Lenti ORF particles, Pla2g3 (Myc-DDK-tagged) - Mouse phospholipase A2, group III (Pla2g3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, Pla2g3 (GFP-tagged) - Mouse phospholipase A2, group III (Pla2g3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PLA2G3 (Myc-DDK tagged) - Human phospholipase A2, group III (PLA2G3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, PLA2G3 (mGFP-tagged) - Human phospholipase A2, group III (PLA2G3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, Pla2g3 (Myc-DDK-tagged ORF) - Rat phospholipase A2, group III (Pla2g3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF particles, Pla2g3 (GFP-tagged ORF) - Rat phospholipase A2, group III (Pla2g3), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Active filters
Category
-
cDNA Clones
- Lentiviral Particles
Target Symbol
- PLA2G3
Filter by
Lentivirus
Tags
Vectors
Mutants
Mammalian Cell Selection
Families
Pathways
- Arachidonic acid metabolism (4)
- Ether lipid metabolism (4)
- Fc epsilon RI signaling pathway (4)
- Glycerophospholipid metabolism (4)
- GnRH signaling pathway (4)
- Linoleic acid metabolism (4)
- Long-term depression (4)
- MAPK signaling pathway (4)
- Metabolic pathways (4)
- VEGF signaling pathway (4)
- Vascular smooth muscle contraction (4)
- alpha-Linolenic acid metabolism (4)